Загрузка...
Phase III, randomized, double‐blind, placebo‐controlled study to evaluate the efficacy and safety of teneligliptin monotherapy in Chinese patients with type 2 diabetes mellitus inadequately controlled with diet and exercise
AIMS/INTRODUCTION: Although the efficacy of teneligliptin, a highly selective dipeptidyl peptidase‐4 inhibitor, has been amply studied for the treatment of type 2 diabetes, no clinical trials of teneligliptin have been carried out in China. We evaluated the efficacy and safety of teneligliptin monot...
Сохранить в:
| Опубликовано в: : | J Diabetes Investig |
|---|---|
| Главные авторы: | , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8015819/ https://ncbi.nlm.nih.gov/pubmed/32810383 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.13389 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|